Latest News

Latest news from the IPHA and the international research-based pharmaceutical industry in Ireland and globally. You may subscribe to the Latest News RSS Feed here.

 

IPHA distributes medicines.ie extract to over 9,000 healthcare professionals (09/05/2014)
Visits to mediicnes.ie website up 41% on 2013

Pharmaceutical industry welcomes move to make more medicinal products available over the counter (07/17/2014)
Thursday 17th July 2014: The Irish Pharmaceutical Healthcare Association (IPHA), which represents the international research based pharmaceutical industry in Ireland, has welcomed the publication by the Health Products Regulatory Authority (HPRA)of a list of twelve active substances (or combinations of substances) contained in medicines currently classified as prescription-only medicines (POM) which could be safely switched from POM to Over The Counter (OTC) sale (sale not subject to medical prescription).

Irish Pharmaceutical Healthcare Association looks forward to working with new Minister for Health (07/14/2014)
The Irish Pharmaceutical Healthcare Association (IPHA) which represents the international research based pharmaceutical industry in Ireland has welcomed the appointment of Mr Leo Varadkar as Minister for Health.

Pharmaceutical industry welcomes Europe’s largest Public Private Partnership in healthcare (07/09/2014)
The Irish Pharmaceutical Healthcare Association (IPHA) which represents the international research-based pharmaceutical industry in Ireland has welcomed the launch in Brussels today of the second Innovative Medicines Initiative (IMI2), marking the continuation of the successful partnership of industry and public bodies efforts in tackling some of the world’s greatest health needs.

Ban on gifts comes into force (07/03/2014)
The national ban on gifts as introduced in the new IPHA Code has come into operation

AESGP Self-Medication Industry Newsletter (06/24/2014)
The latest issue of the AESGP Self-Medication Industry Newsletter which includes:

Pharmaceutical companies can help efficiency through use of electronic signatures (12/17/2013)
Pharmaceutical companies can benefit from the decsion by the European Medicines Agency's (EMA) to accept digital signatures on documents that require a legally binding signature. Since September, the EMA has been using the procedure on documents related to scientific advice for human medicines, orphan medicines and paediatric-medicine procedures.

IPHA welcomes new Health Innovation Hub jobs initiative (12/17/2013)
The Irish Pharmaceutical Healthcare Association (IPHA) has welcomed the announcement by Sláinte Healthcare that it will create 80 new jobs in the coming year, as part of the Health Innovation Hub of which IPHA is an industry partner.

Benefits of partnership emphasised at IPHA Annual Meeting (11/26/2013)
The importance of partnership in healthcare and of exploring new opportunities of working together, was the theme of the 20th Irish Pharmaceutical Healthcare Association (IPHA) Annual meeting held at the RDS Concert Hall today 26th November.

IPHA welcomes OECD findings on improved health outcomes (11/22/2013)
The Irish Pharmaceutical Healthcare Association (IPHA), has welcomed a report by the OECD which shows that life expectancy in Ireland has increased by four years in the period 2000 to 2011, despite the fact that we are at the top of the league in terms of both tobacco and alcohol consumption. The use of innovative medicines contributed significantly to these positive developments.

 

Related Content

Petri dishes
IPHA Press Releases 

IPHA is a member of -

IFPMAAESGPEFPIA

For medicines and clinical trials information visit -

medicines.ieself-care.ieICTRP Portal